<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01543516</url>
  </required_header>
  <id_info>
    <org_study_id>FRA-AKAS</org_study_id>
    <nct_id>NCT01543516</nct_id>
  </id_info>
  <brief_title>Cell Distribution in Induced Sputum in Patients With Asthma</brief_title>
  <official_title>Cell Distribution in Induced Sputum in Healthy Subjects and Patients With Asthma After Different Techniques for Sputum Induction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johann Wolfgang Goethe University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johann Wolfgang Goethe University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this case-control study is the comparison of the cell distribution in induced&#xD;
      sputum in young adults with asthma and in healthy controls.&#xD;
&#xD;
      The study consists of two visits. At both visits subjects are asked to perform a lung&#xD;
      function test (body plethysmography) and levels of exhaled nitric oxide (eNO) are measured.&#xD;
      At the first visit a blood sample is drawn to determine the inflammatory and allergic status&#xD;
      of the subjects and the sputum is induced by an ultrasonic nebulizer. At the second visit&#xD;
      another sputum sample is induced by a nozzle nebulizer. The cell distribution will be&#xD;
      evaluated in both sputum samples.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objectives:&#xD;
&#xD;
      The aim of this study is the characterization of healthy children/ young adults and matched&#xD;
      patients with asthma in terms of lung function, and the degree of the systemic and bronchial&#xD;
      inflammation.&#xD;
&#xD;
      Sputum and serum samples are analyzed by quantitative real-time polymerase chain reaction&#xD;
      (qRT-PCR) and by a cytometric bead assay (CBA). Components of the innate immune system&#xD;
      (mannose-binding protein, TLR recognition proteins and surfactant proteins) are determined&#xD;
      from sputum or blood respectively.&#xD;
&#xD;
      Methods and Work Programme:&#xD;
&#xD;
      This study consists of two study visits (V1 and V2)&#xD;
&#xD;
      V1 (day 0 - duration 1 hour):&#xD;
&#xD;
        -  Measurement of exhaled nitric oxide (eNO)&#xD;
&#xD;
        -  Lung function testing with and body plethysmography&#xD;
&#xD;
        -  Blood test: blood count, CRP, RAST, serum inflammatory mediators, markers of the&#xD;
           non-specific pulmonary defense system&#xD;
&#xD;
        -  Induced sputum attained by an ultrasonic-nebulizer for inflammatory mediators and&#xD;
           microbiological investigations&#xD;
&#xD;
      V2 (day 14-28 - duration 1 hour):&#xD;
&#xD;
        -  Measurement of nitric oxide in expired air (eNO)&#xD;
&#xD;
        -  Lung function testing with spirometry and body plethysmography&#xD;
&#xD;
        -  Induced sputum attained by a nozzle-nebulizer for inflammatory mediators and&#xD;
           microbiological investigations&#xD;
&#xD;
      Study population:&#xD;
&#xD;
      Children, adolescents and young people (6 - 25 years of age). Both the patients and the&#xD;
      healthy subjects are recruited from the outpatient clinic of Pediatric Allergy and&#xD;
      Pulmonology.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">May 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>cell count differences in induced sputum</measure>
    <time_frame>V1 and V2 respectively (V1 (day 0 - duration 1 hour) V2 (day 14-28 - duration 1 hour)</time_frame>
    <description>Differences in neutrophils, macrophages and lymphocytes in subjects with and without asthma</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>differences in cell count depending on the method of sputum induction</measure>
    <time_frame>V1 and V2 respectively (V1 (day 0 - duration 1 hour) V2 (day 14-28 - duration 1 hour)</time_frame>
    <description>At V1 an ultrasonic nebulizer is used for sputum induction. At V2 a breath controlled nozzle nebulizer is used for sputum induction. These different techniques might lead to different cell counts in included subjects.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">40</enrollment>
  <condition>Bronchial Asthma With eNO-levels Greater Than 30 ppB</condition>
  <arm_group>
    <arm_group_label>Patients with Asthma</arm_group_label>
    <description>Affected patients&#xD;
-20 Patients suffering from asthma with an eNO over 30 bbp</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Subjects</arm_group_label>
    <description>Non-affected patients&#xD;
-20 matched controls not suffering from asthma</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood, serum, and sputum&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The study is carried out in children, adolescents, and young adults (6 to 25 years of age).&#xD;
        Both the patients (n=20) and the healthy subjects (n=20) are recruited from the outpatient&#xD;
        clinic of the department of Pediatric Allergy and Pulmonology, University Clinic,&#xD;
        Goethe-University, Frankfurt/M, Germany.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  informed consent&#xD;
&#xD;
          -  between 6 and 25 years of age&#xD;
&#xD;
          -  Known bronchial asthma/no bronchial asthma(depending on the study group)&#xD;
&#xD;
          -  Ability to perform lung function tests and inhalation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  &lt; 6 and &gt; 25 years of age&#xD;
&#xD;
          -  Any acute condition with systemic or bronchial inflammation&#xD;
&#xD;
          -  any chronic condition or infection (e.g. HIV, tuberculosis, malignancy)&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  known alcohol and/ or drug abuse&#xD;
&#xD;
          -  Inability to understand the extent and scope of the study&#xD;
&#xD;
          -  Participation in another study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>25 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Children's Hospital, Goethe-University</name>
      <address>
        <city>Frankfurt am Main</city>
        <state>Hessen</state>
        <zip>60596</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>June 2012</verification_date>
  <study_first_submitted>February 20, 2012</study_first_submitted>
  <study_first_submitted_qc>March 2, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 5, 2012</study_first_posted>
  <last_update_submitted>June 29, 2012</last_update_submitted>
  <last_update_submitted_qc>June 29, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 2, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Johann Wolfgang Goethe University Hospital</investigator_affiliation>
    <investigator_full_name>Dr. med. Martin Rosewich</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Asthma</keyword>
  <keyword>Sputum</keyword>
  <keyword>Blood</keyword>
  <keyword>Inflammation</keyword>
  <keyword>adaptive immune system</keyword>
  <keyword>innate immune system</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

